Strategies for the generation, validation and application of in silico ADMET models in lead generation and optimization. (Q34360291)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22849616%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

Strategies for the generation, validation and application of in silico ADMET models in lead generation and optimization (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22849616%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22849616%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

author name string

Dino Montanari

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22849616%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

language of work or name

English

0 references

publication date

31 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22849616%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Metabolism & Toxicology

9 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22849616%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22849616%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22849616%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

1435-1446

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22849616%20AND%20SRC:MED&resulttype=core&format=json

Can the pharmaceutical industry reduce attrition rates?

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Is there a difference between leads and drugs? A historical perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

ADME-Tox in drug discovery: integration of experimental and computational technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Integrating molecular design resources within modern drug discovery research: the Roche experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

High throughput ADME screening: practical considerations, impact on the portfolio and enabler of in silico ADME models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

21 January 2018

Making priors a priority

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Can we estimate the accuracy of ADME-Tox predictions?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Apparent activity in high-throughput screening: origins of compound-dependent assay interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

A Comparative Study of the CYP450 Inhibition Potential of Marketed Drugs Using Two Fluorescence Based Assay Platforms Routinely Used in the Pharmaceutical Industry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

N-in-1 dosing pharmacokinetics in drug discovery: experience, theoretical and practical considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Derivation and validation of toxicophores for mutagenicity prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

The Ames Salmonella/microsome mutagenicity assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Alternatives to the carcinogenicity bioassay: in silico methods, and the in vitro and in vivo mutagenicity assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Mechanisms of chemical carcinogenicity and mutagenicity: a review with implications for predictive toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Defining and maintaining a high quality screening collection: the GSK experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Trust, but verify: on the importance of chemical structure curation in cheminformatics and QSAR modeling research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Proteochemometric modeling as a tool to design selective compounds and for extrapolating to novel targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

The challenges involved in modeling toxicity data in silico: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Approaches to Measure Chemical Similarity– a Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

On Outliers and Activity Cliffs - Why QSAR Often Disappoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Chemical substitutions that introduce activity cliffs across different compound classes and biological targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Methyl effects on protein-ligand binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Structural Alert/Reactive Metabolite Concept as Applied in Medicinal Chemistry to Mitigate the Risk of Idiosyncratic Drug Toxicity: A Perspective Based on the Critical Examination of Trends in the Top 200 Drugs Marketed in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

ADMET rules of thumb II: A comparison of the effects of common substituents on a range of ADMET parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

On various metrics used for validation of predictive QSAR models with applications in virtual screening and focused library design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Best Practices for QSAR Model Development, Validation, and Exploitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Automated QSAR with a Hierarchy of Global and Local Models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

In silico ADME/Tox: why models fail

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Molecular descriptors in chemoinformatics, computational combinatorial chemistry, and virtual screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

4D-fingerprints, universal QSAR and QSPR descriptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Molecular properties that influence the oral bioavailability of drug candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

A general pattern for substrate recognition by P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

In Silico ADME Prediction: Data, Models, Facts and Myths

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

The Importance of Being Earnest: Validation is the Absolute Essential for Successful Application and Interpretation of QSPR Models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Principles of QSAR models validation: internal and external

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Assessing the accuracy of prediction algorithms for classification: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Components of successful lead generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

FAF-Drugs2: free ADME/tox filtering tool to assist drug discovery and chemical biology projects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

ADMET in silico modelling: towards prediction paradise?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Prediction of ADMET Properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

A review of the electrophilic reaction chemistry involved in covalent DNA binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

In-silico ADME models: a general assessment of their utility in drug discovery applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

In silicosite of metabolism prediction of cytochrome P450-mediated biotransformations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Design of a Potent CB1 Receptor Antagonist Series: Potential Scaffold for Peripherally-Targeted Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Using electrophysiology and in silico three-dimensional modeling to reduce human Ether-à-go-go related gene K(+) channel inhibition in a histamine H3 receptor antagonist program

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Probing the links between in vitro potency, ADMET and physicochemical parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Virtual screening: an endless staircase?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Pursuing the leadlikeness concept in pharmaceutical research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

A ‘Rule of Three’ for fragment-based lead discovery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Quantifying the chemical beauty of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Generation of in-silico cytochrome P450 1A2, 2C9, 2C19, 2D6, and 3A4 inhibition QSAR models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

21 January 2018

A bioavailability score.

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Computational approaches to the prediction of the blood-brain distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Strategies to assess blood-brain barrier penetration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Predicting drug metabolism--an evaluation of the expert system METEOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

A comprehensive listing of bioactivation pathways of organic functional groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Identification of mechanisms of toxic action for skin sensitisation using a SMARTS pattern based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Multi-parameter optimization: identifying high quality compounds with a balance of properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

In silico prediction of volume of distribution in human using linear and nonlinear models on a 669 compound data set.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Findings of the challenge to predict aqueous solubility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Chemical and biological properties of frequent screening hits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Recognizing pitfalls in virtual screening: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Evolving molecules using multi-objective optimization: applying to ADME/Tox

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425255.2012.711317

Estimation of aqueous solubility for a diverse set of organic compounds based on molecular topology

21 January 2018

1 reference

7 December 2024

https://opencitations.net/index/api/v1/citations/10.1021/CI9901338

1 reference

7 December 2024

https://opencitations.net/index/api/v1/citations/10.1021/CI049782W

The characterization of chemical structures using molecular properties. A survey

1 reference

7 December 2024

https://opencitations.net/index/api/v1/citations/10.1021/CI990162I

Identifiers

DOI

10.1517/17425255.2012.711317

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22849616%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference